(Q33905874)

29 July 2017

title

IP-10 response to RD1 antigens might be a useful biomarker for monitoring tuberculosis therapy (English)

1 reference

29 July 2017

0 references

0 references

6

1 reference

Basirudeen Syed Ahamed Kabeer

29 July 2017

object named as

Basirudeen Syed Ahamed Kabeer

1

0 references

Delia Goletti

object named as

Delia Goletti

9

0 references

Enrico Girardi

object named as

Enrico Girardi

7

0 references

author name string

Alamelu Raja

2

1 reference

29 July 2017

Balambal Raman

3

1 reference

29 July 2017

Satheesh Thangaraj

4

1 reference

29 July 2017

Marc Leportier

5

1 reference

29 July 2017

Philippe Henri Lagrange

8

1 reference

29 July 2017

publication date

19 May 2011

1 reference

29 July 2017

published in

BMC Infectious Diseases

1 reference

29 July 2017

volume

11

1 reference

29 July 2017

page(s)

135

1 reference

https://scigraph.springernature.com/pub.10.1186/1471-2334-11-135

29 July 2017

exact match

0 references

cites work

IP-10 detection in urine is associated with lung diseases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3120672

Is IP-10 an accurate marker for detecting M. tuberculosis-specific response in HIV-infected persons?

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3120672

Updated guidelines for using Interferon Gamma Release Assays to detect Mycobacterium tuberculosis infection - United States, 2010.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3120672

Reversion and conversion of Mycobacterium tuberculosis IFN-gamma ELISpot results during anti-tuberculous treatment in HIV-infected children

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3120672

Advances in the diagnosis of tuberculosis

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3120672

Role of QuantiFERON-TB gold, interferon gamma inducible protein-10 and tuberculin skin test in active tuberculosis diagnosis

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3120672

Comparison of interferon gamma and interferon gamma-inducible protein-10 secretion in HIV-tuberculosis patients

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3120672

A 100 year update on diagnosis of tuberculosis infection

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3120672

T-cell interferon-gamma release assays for the rapid immunodiagnosis of tuberculosis: clinical utility in high-burden vs. low-burden settings

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3120672

In vivo and in vitro effects of antituberculosis treatment on mycobacterial interferon-gamma T cell response

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3120672

IP-10, MCP-1, MCP-2, MCP-3, and IL-1RA hold promise as biomarkers for infection with M. tuberculosis in a whole blood based T-cell assay

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3120672

Is IP-10 a better biomarker for active and latent tuberculosis in children than IFNgamma?

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3120672

Accuracy of immunodiagnostic tests for active tuberculosis using single and combined results: a multicenter TBNET-Study.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3120672

Evaluating the potential of IP-10 and MCP-2 as biomarkers for the diagnosis of tuberculosis

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3120672

Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: an update

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3120672

Response to M. tuberculosis selected RD1 peptides in Ugandan HIV-infected patients with smear positive pulmonary tuberculosis: a pilot study

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3120672

Sensitivity of a whole-blood interferon-gamma assay among patients with pulmonary tuberculosis and variations in T-cell responses during anti-tuberculosis treatment

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3120672

Isoniazid prophylaxis differently modulates T-cell responses to RD1-epitopes in contacts recently exposed to Mycobacterium tuberculosis: a pilot study

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3120672

Serial testing of health care workers for tuberculosis using interferon-gamma assay

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3120672

Reversion of the ELISPOT test after treatment in Gambian tuberculosis cases

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3120672

Effect of treatment of latent tuberculosis infection on the T cell response to Mycobacterium tuberculosis antigens

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3120672

Selected RD1 peptides for active tuberculosis diagnosis: comparison of a gamma interferon whole-blood enzyme-linked immunosorbent assay and an enzyme-linked immunospot assay

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3120672

IFN-gamma-inducible protein 10 and pentraxin 3 plasma levels are tools for monitoring inflammation and disease activity in Mycobacterium tuberculosis infection

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3120672

Identification of early secretory antigen target-6 epitopes for the immunodiagnosis of active tuberculosis.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3120672

Molecular analysis of genetic differences between Mycobacterium bovis BCG and virulent M. bovis

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3120672

Evidence for occurrence of the ESAT-6 protein in Mycobacterium tuberculosis and virulent Mycobacterium bovis and for its absence in Mycobacterium bovis BCG.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3120672

Persistence and turnover of antigen-specific CD4 T cells during chronic tuberculosis infection in the mouse.

28 July 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-11-135

Interferon-gamma responses after isoniazid chemotherapy for latent tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-11-135

Use of a T cell-based assay for monitoring efficacy of antituberculosis therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-11-135

Do results of the T-SPOT.TB interferon-gamma release assay change after treatment of tuberculosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-11-135

IFN-γ, but not IP-10, MCP-2 or IL-2 response to RD1 selected peptides associates to active tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-11-135

Potential of interferon-γ-inducible protein 10 in improving tuberculosis diagnosis in HIV-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-11-135

Region of difference 1 antigen-specific CD4+ memory T cells correlate with a favorable outcome of tuberculosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-11-135

Specific detection of tuberculosis infection: an interferon-gamma-based assay using new antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-11-135

Chemokine IP-10: an adjunct marker for latent tuberculosis infection in children.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3120672

Use of the QuantiFERON-TB Gold In-Tube test to monitor treatment efficacy in active pulmonary tuberculosis.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3120672

Development of diagnostic reagents to differentiate between Mycobacterium bovis BCG vaccination and M. bovis infection in cattle

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3120672

Enzyme-Linked Immunospot Assay Responses to Early Secretory Antigenic Target 6, Culture Filtrate Protein 10, and Purified Protein Derivative among Children with Tuberculosis: Implications for Diagnosis and Monitoring of Therapy

29 October 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-11-135

The Potential of the ESAT-6 Antigen Secreted by Virulent Mycobacteria for Specific Diagnosis of Tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-11-135

T-cell responses to the Mycobacterium tuberculosis-specific antigens in active tuberculosis patients at the beginning, during, and after antituberculosis treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-11-135

Tuberculin sensitivity among children vaccinated with BCG under universal immunization programme

21 January 2018

1 reference

12 December 2020

Sensitivity of Ziehl-Neelsen method for centrifuged deposit smears of sputum samples transported in cetyl-pyridinium chloride

1 reference

12 December 2020

Transitional changes in T-cell responses to Mycobacterium tuberculosis-specific antigens during treatment

1 reference

12 December 2020

Latent tuberculosis infection treatment and T-cell responses to Mycobacterium tuberculosis-specific antigens

1 reference

12 December 2020

CXCL10/IP-10 release is induced by incubation of whole blood from tuberculosis patients with ESAT-6, CFP10 and TB7.7

1 reference

12 December 2020

Direct ex vivo analysis of antigen-specific IFN-gamma-secreting CD4 T cells in Mycobacterium tuberculosis-infected individuals: associations with clinical disease state and effect of treatment

1 reference

12 December 2020

Identifiers

DOI

10.1186/1471-2334-11-135

1 reference

29 July 2017

1 reference

29 July 2017

1 reference